Infection with hepatitis B is the biggest known risk factor for developing primary liver cancer in Australia.
The hepatitis B virus affects the liver cells. This stimulates the immune system to attack the virus. However, the immune response causes inflammation in the liver, which can lead to ongoing damage.
To reduce the spread of hepatitis B and the incidence of primary liver cancer, it is recommended that all at-risk people receive a vaccination against the virus.